Sporadic Angiomyolipomas (AMLs)

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Sporadic Angiomyolipomas (AMLs) trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

TerminatedPhase 2

NCT02539459

Sporadic Angiomyolipomas (AMLs) Growth Kinetics While on Everolimus

The purpose of this research study is to see if oral everolimus is tolerable and effective in the treatment of sporadic Angiomyolipomas (AMLs). AMLs are the mos…

United States20 participantsStarted 2015-09-23

Treatment: Everolimus